Categories AlphaGraphs, Earnings, Health Care
Merck (MRK) swings to profit in Q2 on higher revenues; earnings beat
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported net profit for the second quarter of 2024, on an adjusted basis, compared to a loss last year. Both sales and earnings exceeded the market’s expectations.
Second-quarter worldwide sales increased 7% year-over-year to $16.11 billion, mainly reflecting continued growth in the sales of vaccines and oncology/cardiovascular products. Wall Street was looking for slower growth.
The company reported a net profit of $5.46 billion or $2.14 per share for the June quarter, compared to a loss of $5.98 billion or $2.35 per share in the prior-year period. On an adjusted basis, net income was $2.28 per share, compared to a loss of $2.06 per share in the second quarter of 2023. The bottom line topped expectations.
“I am proud of our dedicated teams around the world that are working tirelessly to advance our deep pipeline as we continue delivering innovation that solves unmet medical needs,” said Merck’s CEO Robert Davis.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
What to look for when Halliburton Company (HAL) reports Q4 2024 results?
Halliburton Company (NYSE: HAL) is expected to report fourth-quarter results on Wednesday, January 22, at 6:45 am ET. The oilfield service provider is currently recovering from a rough patch, marked
McCormick (MKC) is set to report Q4 2024 earnings results next week, a few points to note
Shares of McCormick & Company, Incorporated (NYSE: MKC) rose over 1% on Thursday. The stock has gained 12% in the past 12 months. The company is scheduled to report its fourth quarter
PNC Financial Q4 2024 profit more than doubles; revenue up 4%
The PNC Financial Services Group, Inc. (NYSE: PNC) reported a sharp increase in profit for the fourth quarter of 2024. Revenues grew by 4%. Net income attributable to common shareholders